mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.01 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |